curriculum vitae - university of utah€¦ · curriculum vitae last updated: 04/27/2018 personal...

21
Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster Birth Place: Detroit, Michigan Citizenship: United States EDUCATION Years Degree Institution (Area of Study) 1970 - 1974 B.S. Purdue University (Chemistry) West Lafayette, IN 1974 - 1978 M.D. Washington University (Medicine) St. Louis, MO 1978 - 1979 Intern University of Utah School of Medicine (Pediatrics) Salt Lake City, UT 1979 - 1981 Resident University of Utah School of Medicine (Pediatrics) Salt Lake City, UT 1981 - 1984 Fellow National Institutes of Health (Pediatric Endocrinology) Bethesda, MD 1984 - 1985 Fellow University of Michigan (Pediatric Endocrinology) Ann Arbor, MI 1984 - 1985 Fellow University of Michigan, Laboratory of J Schwartz (Physiology) Ann Arbor, MI 1995 - 1996 Postdoctoral Training University of Michigan, Laboratory of Dr. KMJ Menon (Reproductive Endocrinology) Ann Arbor, MI BOARD CERTIFICATIONS 01/01/1983 - Present American Board of Pediatrics (Sub: Pediatric Endocrinology), Certified 11/18/1983 - Present American Board of Pediatrics (Pediatrics), Certified ACADEMIC HISTORY Pediatrics (Pediatric Endocrinology), 08/01/2005 - Present 08/01/2005 Hire, Tenure Track - Clinician Scholar, Professor 07/01/2007 Tenure PROFESSIONAL EXPERIENCE Full-Time Positions 1985 - 1993 Assistant Professor, University of Michigan, Department of Pediatrics and Communicable Diseases, Ann Arbor, MI 1993 - 1999 Associate Professor, University of Michigan, Department of Pediatrics and Communicable Diseases, Ann Arbor, MI 1996 - 1999 Associate Research Scientist, University of Michigan, Reproductive Sciences Program, Ann Arbor, MI Foster, Page 1

Upload: others

Post on 23-Jun-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

Curriculum VitaeLast Updated: 04/27/2018

PERSONAL DATAName: Carol M. FosterBirth Place: Detroit, MichiganCitizenship: United States

EDUCATIONYears Degree Institution (Area of Study)1970 - 1974 B.S. Purdue University (Chemistry)

West Lafayette, IN1974 - 1978 M.D. Washington University (Medicine)

St. Louis, MO1978 - 1979 Intern University of Utah School of Medicine (Pediatrics)

Salt Lake City, UT1979 - 1981 Resident University of Utah School of Medicine (Pediatrics)

Salt Lake City, UT1981 - 1984 Fellow National Institutes of Health (Pediatric Endocrinology)

Bethesda, MD1984 - 1985 Fellow University of Michigan (Pediatric Endocrinology)

Ann Arbor, MI1984 - 1985 Fellow University of Michigan, Laboratory of J Schwartz (Physiology)

Ann Arbor, MI1995 - 1996 Postdoctoral Training University of Michigan, Laboratory of Dr. KMJ Menon

(Reproductive Endocrinology) Ann Arbor, MI

BOARD CERTIFICATIONS01/01/1983 - Present American Board of Pediatrics (Sub: Pediatric Endocrinology), Certified11/18/1983 - Present American Board of Pediatrics (Pediatrics), Certified

ACADEMIC HISTORYPediatrics (Pediatric Endocrinology), 08/01/2005 - Present08/01/2005 Hire, Tenure Track - Clinician Scholar, Professor07/01/2007 Tenure

PROFESSIONAL EXPERIENCE

Full-Time Positions1985 - 1993 Assistant Professor, University of Michigan, Department of Pediatrics and

Communicable Diseases, Ann Arbor, MI1993 - 1999 Associate Professor, University of Michigan, Department of Pediatrics and

Communicable Diseases, Ann Arbor, MI1996 - 1999 Associate Research Scientist, University of Michigan, Reproductive Sciences

Program, Ann Arbor, MI

Foster, Page 1

Page 2: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

1997 - 1998 Interim Director, University of Michigan, Department of Pediatrics, Division ofEndocrinology, Ann Arbor, MI

1998 - 2002 Director, University of Michigan, Department of Pediatrics and CommunicableDiseases, Division of Endocrinology, Ann Arbor, MI

1998 - 2005 Associate Director, University of Michigan, General Clinical Research Center, AnnArbor, MI

1999 - 2005 Professor, University of Michigan, Department of Pediatrics and CommunicableDiseases, Ann Arbor, MI

2005 - Present Professor, University of Utah School of Medicine, Department of Pediatrics,Division of Pediatric Endocrinology, Salt Lake City, UT

Part-Time Positions1986 - 1992 Supervising Physician, Hurley Hospital Pediatric Endocrinology Clinic, Flint, MI1992 - 2005 Supervising Physician, Genesys Regional Medical Center, Pediatric Endocrinology

Clinic, Grand Blanc, MI2005 - 2007 Adjunct Professor, University of Michigan, Department of Pediatrics and

Communicable Diseases, Ann Arbor, MI

Reviewer ExperienceAd Hoc Reviewer for American Journal of Medical GeneticsAd Hoc Reviewer for American Journal of PhysiologyAd Hoc Reviewer for BloodAd Hoc Reviewer for Diabetes CareAd Hoc Reviewer for EndocrineAd Hoc Reviewer for Endocrine ReviewsAd Hoc Reviewer for EndocrinologyAd Hoc Reviewer for Fertility & SterilityAd Hoc Reviewer for Human ReproductionAd Hoc Reviewer for Journal of Clinical Endocrinology and MetabolismAd Hoc Reviewer for Journal of Endocrinological InvestigationsAd Hoc Reviewer for Journal of Pediatric & Adolescent PsychiatryAd Hoc Reviewer for Pediatric ResearchAd Hoc Reviewer for PediatricsReviewer for Endocrine Society National Meeting

Ad Hoc/Site Visit2002 National Institutes of Health, Heart Lung and Blood Institute, Clinical Research

Center Site Visit

SCHOLASTIC HONORS1973 Phi Kappa Phi1974 Phi Beta Kappa1974 Phi Lambda Upsilon, Chemistry Honorary1976 Summer Research Fellowship, Washington University, St. Louis, MO1984 - 1985 NIH Postdoctoral Fellow in Endocrinology and Metabolism, University of Michigan1985 Outstanding Young Women of America1985 - 1986 Clinical Associate Physician Award, University of Michigan

Foster, Page 2

Page 3: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

2001 - 2007 Certified Pediatric Provider, American Diabetes Association2001 - 2017 Top Doctors in America2004 - 2005 America's Top Pediatricians

ADMINISTRATIVE EXPERIENCE

Administrative Duties1997 - 2005 Fellowship Director, Endocrinology, Pediatrics and Communicable Diseases,

University of Michigan1997 - 1998 Interim Director, Division of Endocrinology, Department of Pediatrics and

Communicable Diseases, University of Michigan, Ann Arbor, Michigan.1998 - 2002 Director, Division of Endocrinology, Department of Pediatrics and Communicable

Diseases, University of Michigan, Ann Arbor, Michigan.1998 - 2005 Associate Director, General Clinical Research Center, University of Michigan, Ann

Arbor, Michigan.2015 - Present Fellowship Director, University of Utah, Department of Pediatrics/Endocrinology

Professional Organization & Scientific Activities1994 - 1997 Member, Lawson Wilkins Pediatric Endocrine Society, Nominating Committee1995 Abstract Reviewer, Midwestern Society of Pediatric Research1995 Abstract Reviewer, Endocrine Society, National meeting Abstracts (Growth

Hormone section)1996 - 1997 Chair, Lawson Wilkins Pediatric Endocrine Society, Nominating Committee1997 Moderator, Endocrine Society, Precocious Puberty Symposium, 79th Annual

Meeting, Minneapolis, MN

Grant Review Committee/Study Section1988 - 2005 General Clinical Research Center, University of Michigan1990 Biomedical Research Committee, University of Michigan1990 - 2005 Office of the Vice President for Research, University of Michigan1994 The Israeli Science Foundation1998 Burroughs Welcome Foundation, England1998 National Institutes of Health, Biological and Physiological Sciences Special

Emphasis Panel, ZRG 2 END 012004 National Institutes of Health, Reproductive Biology2005 - Present Primary Childrens Medical Center Foundation2006 NIH NCRR Special Emphasis Panel

ZRR1 CR-3

PROFESSIONAL COMMUNITY ACTIVITIES1994 - 1998 Ad Hoc Member, Michigan State University, Pediatric Endocrinology Advisory

Council of Michigan1998 - 2001 Chair, Michigan State University, Pediatric Endocrinology Advisory Council of

Michigan2008 - 2010 Advisory Board Member, Utah Department of Health, Utah Partners for a Health

Weight/PANO

Foster, Page 3

Page 4: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

UNIVERSITY COMMUNITY ACTIVITIES

University Level2009 - 2012 Advisory Committee Member, University Retention, Promotion, and Tenure

Standards Committee, University of Utah RPT Standards Committee

SERVICE AT AFFILIATED INSTITUTIONS2006 - 2008 Advisor, Intermountain Healthcare, Care Process Model for Pediatric Obesity2006 Committee Member, Intermountain Healthcare, Pediatric Obesity Care Process

Model2006 - 2009 Committee Member, Primary Children's Medical Center, Primary Children's

Medical Center Outpatient Electronic Medical Records Committee

SERVICE AT PREVIOUS INSTITUTIONS1987 Member, University of Michigan, Pediatric Intradepartmental Review Committee,

Department of Pediatrics1990 Member, University of Michigan, Search Committee, Ambulatory Care Director,

Department of Pediatrics1992 Member, University of Michigan, Trainee Selection Committee, Reproductive

Sciences Program1992 - 1994 Member, University of Michigan, Pediatric Research Advisory Committee,

Department of Pediatrics1995 Member, University of Michigan, East Medical Center Ambulatory Care Planning

Task Force, Department of Pediatrics1996 - 2000 Member, University of Michigan, Clinical Affairs Committee, Department of

Pediatrics1997 - 1998 Member, University of Michigan, Pediatric Psychologist Search Committee,

Department of Pediatrics1997 - 1998 Member, University of Michigan, Pediatric Outreach Clinics Committee,

Department of Pediatrics1998 Member, University of Michigan, Comprehensive Multidisciplinary Specialty Clinics

Committee, Department of Pediatrics1998 - 1999 Member, University of Michigan, Research Advisory Task Force, Department of

Pediatrics1998 - 2005 Member, University of Michigan, Training Program in Clinical Research (K30)

Advisory Committee, Medical School1999 Member, University of Michigan, Administration Advisory Task Force, Department

of Pediatrics1999 - 2001 Member, University of Michigan, Program Committee, Reproductive Sciences

Program1999 - 2001 Member, University of Michigan, Executive Committee, Reproductive Sciences

Program2001 Member, University of Michigan, Search Committee, Brehm Professorship for

Type 1 Diabetes Mellitus2001 - 2002 Member, University of Michigan, Trainee Selection Committee, Reproductive

Sciences Program2003 Member, University of Michigan, Search Committee, Pediatric Psychology

Director, Department of PediatricsFoster, Page 4

Page 5: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

2004 - 2005 Member, University of Michigan Medical School, Institutional Review Board

CURRENT MEMBERSHIPS IN PROFESSIONAL SOCIETIESAmerican Association for the Advancement of ScienceAmerican Diabetes AssociationAmerican Federation for Clinical ResearchAmerican Pediatric SocietyEndocrine SocietyJuvenile Diabetes Research Foundation InternationalMidwestern Society of Pediatric ResearchPediatric Endocrine SocietySociety for Pediatric Research

FUNDING

Active Grants11/29/04 - Present TrialNet Pathway to Prevention, formerly "TrialNet Natural History Study of the

Development of Type 1 Diabetes" National Institute of Diabetes and Digestive and Kidney Diseases Role: Site Principal Investigator

07/19/07 - Present Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 DiabetesMellitus National Institute of Diabetes and Digestive and Kidney Diseases Role: Site Principal Investigator

06/01/10 - 03/31/15 K23 Changes In Adipokines and Adiposity during Puberty and Young Adulthood Principal Investigator: Nicole L. Mihalopoulos Direct Costs: $660,000 Total Costs: $712,800 National Heart, Lung, and Blood Institute Role: Advisor

04/19/11 - Present A Self-Regulation Approach to Diabetes Adherence into Emerging Adulthood National Institute of Diabetes and Digestive and Kidney Diseases Role: Co Investigator

06/05/11 - Present The T1D Exchange Type 1 Diabetes Network Jaeb Center For Health Research Role: Co Investigator

01/08/14 - Present Long Term Investigative Follow-up in TrialNet (LIFT) University of South Florida Role: Site Principal Investigator

08/06/14 - Present Anti-CD3 MAB (Teplizumab) for Prevention of Diabetes in Relatives at-risk forType 1 Diabetes Mellitus University of South Florida Role: Site Principal Investigator

Past Grants01/01/85 - 01/01/86 Effects of Biosynthetic Human Growth Hormone in Hypopituitary Children.

Lilly Research Laboratories Role: Co-Investigator

Foster, Page 5

Page 6: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

12/11/85 - 11/30/87 NIH, SMO1-RR-00042Influence of Gonadal Steroids on Growth Hormone Concentrations and Activities.University of Utah General Clinical Research Center Role: Clinical Associate Physician

01/01/86 - 12/31/86 Interaction of Growth Hormone Gonadal Steroids in 3T3 Adipocytes. RackhamSchool of Graduate Studies Faculty Grant. Principal Investigator: Carol M. Foster University of Michigan Role: Principal Investigator

04/01/86 - 03/31/87 Interaction of Growth Hormone and Gonadal Steroids in 3T3 Adipocytes.Michigan Memorial Phoenix Project. Principal Investigator: Carol M. Foster University of Michigan Role: Principal Investigator

07/01/86 - 12/31/87 Interaction of Growth Hormone and Insulin in 3T3 Adipocytes. Principal Investigator: Carol M. Foster American Diabetes Association Role: Principal Investigator

05/11/88 - 04/30/93 Influence of Gonadal Steroids on Growth Hormone and Gonadotropin BiologicalActivity. University of Michigan. Principal Investigator: Carol M. Foster University of Utah General Clinical Research Center Role: Principal Investigator

03/01/91 - 08/31/96 NIH RO1-HDI6000.Maturational Roles of GnRH Pulse Frequency. Principal Investigator: Carol M. Foster National Institute of Child Health and Human Development Role: Principal Investigator

07/01/91 - 06/30/92 Radioimmunoassay of Growth Hormone-Binding Protein. Michigan MemorialPhoenix Project. Principal Investigator: Carol M. Foster University of Michigan Role: Principal Investigator

08/01/91 - 08/31/92 Nafarelin Trials (three trials in men, women and children). Syntex Research Role: Co-Investigator

10/01/91 - 12/30/93 NIH R5O-DK43413 Shannon Award. Growth Hormone Secretion and Action. Principal Investigator: Carol M. Foster National Institute of Diabetes and Digestive and Kidney Diseases Role: Principal Investigator

10/11/91 - 09/30/93 Growth Hormone Secretion and Action. Office of the Vice President forResearch. Principal Investigator: Carol M. Foster University of Michigan Role: Principal Investigator

Foster, Page 6

Page 7: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

10/01/92 - 09/30/94 NIH U54-HD29184.Growth Hormone Activity in Granulosa Cells. National Center for InfertilityResearch at Michigan. Principal Investigator: Carol M. Foster National Institute of Child Health and Human Development Role: Principal Investigator

09/01/93 - 08/31/94 Correlates of Risk Behavior and Health Outcomes in Youths with DiabetesMellitus. Child Adolescent Health Behavior Research Center. University of Michigan Role: Co-Investigator

05/01/95 - 04/30/96 Estradiol Regulation of Growth Hormone Secretion and Action. Principal Investigator: Carol M. Foster Direct Costs: $95,000 Total Costs: $95,000 Genentech Foundation For Growth and Development Role: Co-Principal Investigator

07/01/95 - 06/30/96 A Double-Blind, Placebo-Controlled, Randomized, Ascending Single and MultipleOral Dose Safety and Tolerance Study of GPA-748 in Growth HormoneDeficient Children. Wyeth-Ayerst Research Role: Co-Investigator

02/01/97 - 12/31/97 Neuroendocrine Control of Puberty. Office of the Vice President for Research. Principal Investigator: Carol M. Foster Direct Costs: $10,000 Total Costs: $10,000 University of Michigan Role: Principal Investigator

05/01/97 - 11/30/01 Effect of Obesity Control on Growth. Principal Investigator: Carol M. Foster Direct Costs: $90,000 Total Costs: $90,000 Genentech Foundation For Growth and Development Role: Principal Investigator

04/01/98 - 03/31/03 NIH RO-1 HDI6000.Neuroendocrine Control of Puberty. Principal Investigator: Carol M. Foster Direct Costs: $418,515 Total Costs: $418,515 National Institute of Child Health and Human Development Role: Principal Investigator

01/01/99 - 01/01/05 NIH K30 RFA-OD-9807.Training Program in Clinical Research. Direct Costs: $933,792 Total Costs: $933,792 National Institutes of Health Role: Co-Investigator

01/01/00 - 01/01/05 Training Program in Endocrinology and Metabolism. Direct Costs: $1,114,624 Total Costs: $1,114,624 National Institutes of Health Role: Co-Investigator

Foster, Page 7

Page 8: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

07/01/00 - 06/30/01 Hypothalamic Secretion of GHRH. Advisory Council for Clinical Research. Principal Investigator: Carol M. Foster Direct Costs: $25,041 Total Costs: $25,041 University of Michigan Role: Principal Investigator

01/01/01 - 01/01/05 Training Program in Reproductive Endocrinology (support for four pre-doctoraland three post-doctoral trainees). Direct Costs: $820,567 Total Costs: $820,567 National Institutes of Health Role: Co-Investigator

04/01/01 - 09/30/05 Medicaid Demonstration Project. Direct Costs: $270,000 Total Costs: $270,000 State of Michigan Role: Co-Investigator

08/01/01 - 07/30/04 Hypoglycemia and Quality of Life: Comparison of Insulin Therapies in Pre-SchoolAge ChildrenResearch Fund Principal Investigator: Carol M. Foster Direct Costs: $20,000 Total Costs: $20,000 C.S. Mott Children's Hospital Role: Principal Investigator

07/01/02 - 09/30/03 Basal/Bolus Therapy with Insulin Aspart (NovoLog(R)) versus Regular HumanInsulin (Novolin(R)) or Insulin Lispro (Humalog(R)) in Combination with NPH:An Open-Label Randomized, Parallel Group, Multicenter Study in Children andAdolescents with Type 1 Diabetes. Principal Investigator: Carol M. Foster Direct Costs: $37,000 Total Costs: $37,000 Novo Nordisk Pharmaceuticals, Inc. Role: Principal Investigator

02/28/03 - 03/31/04 Diabetes Prevention Trial 1. NIH Multicenter Trial. Direct Costs: $17,000 Total Costs: $17,000 National Institutes of Health Role: Local Site Coordinator

04/02/03 - 03/31/07 Diabetes TrialNet. NIH Multicenter Trial. National Institutes of Health Role: Local Site Coordinator

09/30/04 - 06/30/05 NIH R21 DK069877-01.Detection and treatment of nephropathy in DM type 1. Direct Costs: $270,000 Total Costs: $270,000 National Institute of Diabetes and Digestive and Kidney Diseases Role: Co-Investigator

10/01/04 - 09/30/05 Endocrine Follow-up of New Born Screening. New Born Screening Program. Direct Costs: $267,000 Total Costs: $267,000 State of Michigan Role: Co-Principal Director

Foster, Page 8

Page 9: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

02/01/06 - 01/31/08 FSH and the Onset of Puberty Principal Investigator: Carol M. Foster Direct Costs: $25,000 Total Costs: $25,000 Primary Children's Medical Center Foundation Role: Principal Investigator

10/01/07 - 03/31/10 Lupron Protocol L-Cp07-167 Principal Investigator: Carol M. Foster Direct Costs: $48,197 Total Costs: $59,392 TAP Pharmaceutical Products, Inc. Role: Principal Investigator

08/01/08 - 04/30/13 Type 1 Diabetes TrialNet Principal Investigator: David L. Donaldson Direct Costs: $727,696 Total Costs: $988,465 NIDDK Role: Co-Investigator

05/01/13 - 04/30/15 Metformin Therapy In T1d Principal Investigator: Carol M. Foster Direct Costs: $13,870 Total Costs: $14,990 Jaeb Center For Health Research Role: Principal Investigator

Active Contracts07/01/16 - 06/30/17 Nn12118-4101

Direct Costs: $160,863 Total Costs: $201,014 Novo Nordisk Pharmaceuticals, Inc. Role: Site Principal Investigator

Past Contracts08/01/06 - 10/31/11 A Prospective, Randomized Two-Arm Study to Compare the Efficacy of the

Medtronic MiniMed Paradigm Real-Time System Versus MU Principal Investigator: Carol M. Foster Medtronic, Inc. Role: Principal Investigator

09/01/07 - 10/31/14 Astrazeneca Mccune Albright Principal Investigator: Carol M. Foster Direct Costs: $68,074 Total Costs: $90,334 AstraZeneca Role: Principal Investigator

08/21/08 - Present The Norditropin National Registry Program (NNRP) Principal Investigator: Carol M. Foster Novozymes A/S Role: Principal Investigator

TEACHING RESPONSIBILITIES/ASSIGNMENTS

Education Administration2006 - Present Fellowship Program Director, Division of Pediatric Endocrinology

Foster, Page 9

Page 10: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

Course and Curriculum Development2000 - 2002 Committee member, Curriculum Revision for Introduction to Clinical Skills,

Endocrinology Section.

Course Lectures2000 - 2005 Instructor, Pediatrics Annual Board Review, University of Michigan. residents,

pediatricians2000 - Present Instructor, Reproductive Endocrinology. course taught in the last five years, second

year medical students2000 - Present Instructor, Reproductive Endocrinology Program Annual Seminar. course taught in

the last five years2000 - Present Instructor, Metabolism/Endocrinology and Diabetes Annual Seminar. course taught

in the last five years2005 - Present Instructor, Pediatric Endocrinology Conferences, University of Utah. course taught

in the last five years, two per year

Clinical Teaching2005 - Present Supervise Pediatric and Family Practice Houseofficers and Medical Students in

care of children with endocrinological disorders in an inpatient setting2005 - Present Supervise Pediatric Residents in Endocrinology Clinic

Small Group Teaching2005 - Present Physiology and Pathophysiology of Puberty

Trainee SupervisionFaculty2000 - 2005 Pediatric Faculty Mentor, Najeeb Zoubi, M.D., Pediatric GI, Clinical Assistant

Professor2000 - 2005 Pediatric Faculty Mentor, Susanna Patton, Ph.D., Pediatric Psychology, Clinical

Assistant Professor2006 - Present Advisor/Mentor, Nicole Mihalopoulos, University of Utah. K23 Adiposity and

AdiponectinsFellow2000 - 2005 Supervisor, Daily supervision (~ 5 hours/week) of Pediatric Endocrine Fellow

Training2000 - 2005 Supervisor, Pediatric Endocrine Fellows' Journal Club once a month2000 - 2005 Supervisor, Pediatric Endocrinology case presentations twice a month2000 - 2005 Supervisor, P.M. Hale, Laboratory Research, Pediatric Endocrine Fellow2000 - 2005 Supervisor, G.B. Kletter, Laboratory Research, Pediatric Endocrine Fellow2000 - 2005 Supervisor, J. Hassing, Laboratory Research, Pediatric Endocrine Fellow2000 - 2005 Supervisor, M.S. Racine, Laboratory Research, Pediatric Endocrine Fellow2000 - 2005 Supervisor, A.P. Cemeroglu, Laboratory Research, Pediatric Endocrine Fellow2000 - 2005 Supervisor, Pediatric Endocrine Consult Attending Physician for Pediatric and

Adult Endocrine Fellows, (3 months/year and 5 clinics/month)2000 - 2005 Supervisor, D.D. Elsholz, Laboratory Research, Pediatric Endocrine Fellow2000 - 2005 Supervisor, Elani Dimarki, Internal Medicine Endocrinology Fellow

Foster, Page 10

Page 11: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

2000 - 2005 Supervisor, T.M. Mendes, Laboratory Research, Pediatric Endocrine Fellow2015 - Present Supervisor, Jenny Tkach, University of Utah2015 - Present Supervisor, Mallika Mutyala, University of UtahResident2000 - 2005 Research Mentor, Julia Warren-Ulanch, M.D., "Pomp and Circumstance: The

effect of high-school graduation on self-care of patients with Type 1 diabetes."Awarded American Academy of Pediatrics Resident Research Grant, 2001

2000 - 2005 Supervisor, Laboratory Research, Pediatric Resident (1)2000 - 2005 Supervisor, General Pediatric Attending Physician for Pediatric Housestaff (1-2

months/year)2000 - 2005 Supervisor, Pediatric Endocrine Consult Attending Physician for Pediatric

Housestaff (3 months/year and 5 clinics/month)2000 - 2005 Supervisor, Laboratory Research, Women in Science Summer Intern (1)2005 - Present Supervisor, University of Utah. Supervision of Resident training in Pediatric

Endocrinology 1 1/2 days per week and on inpatient service 1 week per monthPhD/Doctorate2000 - 2005 Supervisor, Emily Fredericks, Pediatric Psychology Post-doc2000 - 2005 Supervisor, General Pediatric Attending Physician for Pharmacy Students (1-2

months/year)2000 - 2005 Supervisor, Alan Silverman, Pediatric Psychology Post-doc2000 - 2005 Supervisor, Jessica Kichler, Pediatric Psychology Post-docMedical Student2000 - 2005 Supervisor, Pediatric Endocrine Consult Attending Physician for Medical Students

(3 months/year and 5 clinics/month)2000 - 2005 Supervisor, Laboratory Research, Medical Student (1)2000 - 2005 Supervisor, General Pediatric Attending Physician for Medical Students (1-2

months/year)Undergraduate2000 - 2005 Faculty Mentor, University of Michigan. Undergraduate Peer-Mentored Group,

Mentorship Program2000 - 2005 Supervisor, Laboratory Research, Undergraduate Students (8)2000 - 2005 Supervisor, Laboratory Research, Post Baccalaureate Program Student (1)2000 - 2005 Faculty Sponsor, University Undergraduate Research Opportunities Program (1-2

students/year)

Educational Lectures

Didactic Lectures1991 Presentation, Congenital Hypothyroidism, parents of children with congenital

hypothyroidism, State of Michigan Conference1992 Presentation, Congenital Hypothyroidism, parents of children with congenital

Hypothyroidism, State of Michigan Conference1992 Presentation, Women in Science, 5th grade students of Northside Elementary

School1993 Presentation, Endocrine Glands, 5th grade students of Abbot Elementary

School

Foster, Page 11

Page 12: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

1996 Presentation, Thinking Science for Life, 4th grade students of Burns ParkElementary

1997 Presentation, What's New In Diabetes Care, Diabetes Fun Night Picnic1997 Presentation ,The Diabetes Prevention Trial, Plymouth/Canton Diabetes

Support Group1997 Presentation, Endocrine Glands, 5th grade students of Burns Park Elementary1998 Presentation, Diabetes in Cystinosis, National Cystinosis Foundation2002 Presentation, Diabetes in Youth Program, Toledo, Ohio2002 Presentation, Diabetes Education day, Livingston Lion's Club

Continuing Education

CE Courses Taught1982 "Glucocorticoid receptor structure in human leukemia and lymphoma."

Dartmouth College1983 "Diagnosis and Treatment of Precocious Puberty." University of Arkansas1983 "Dexamethasone-21-mesylate Labeling of Rat and Human Glucocorticoid

Receptors." National Cancer Institute, Bethesda, Maryland1986 "An Update on the Management of Diabetes Mellitus." Mt. Carmel Mercy

Hospital, Detroit, Michigan1988 "Normal and Abnormal Puberty." Bronson Hospital, Kalamazoo, Michigan1990 "What to do with the Newborn with Ambiguous Genitalia." Bronson Hospital,

Kalamazoo, Michigan1990 "Hypoglycemia." Mt. Carmel Mercy Hospital, Detroit, Michigan1990 "Slow Growth." Mt. Carmel Mercy Hospital, Detroit, Michigan1991 "Adrenal Disorders and Sex Hormones." Pediatric Board Review, University

of Michigan Department of Pediatrics, Ann Arbor, Michigan1991 - 1992 Monthly lecture series on Pediatric Endocrinology, Hurley Hospital1992 "Thyroid Disorders in Children." Pediatric Board Review Course, University

of Michigan Department of Pediatrics, Ann Arbor, Michigan1993 "Congenital Adrenal Hyperplasia - What's New for '93." St. Joseph Hospital

Family Practice Training Program, Flint, Michigan1993 "Adrenal Disorders and Sex Hormones." Pediatric Board Review Course,

University of Michigan Department of Pediatrics, Ann Arbor, Michigan1994 "Endocrine Hormones and Pubertal Maturation," Endocrine Conference,

University of Utah School of Medicine, Salt Lake City, Utah1994 "Carbohydrate Disorders," Pediatric Board Review Course University of

Michigan Department of Pediatrics1994 "Adrenal Disorders and Sex Hormones," Pediatric Board Review Course,

University of Michigan Department of Pediatrics1994 "Newborn Screening for Congenital Hypothyroidism and Congenital Adrenal

Hyperplasia," Michigan State Medical Society Annual Meeting, Dearborn,Michigan

1996 "Carbohydrate Disorders," Pediatric Board Review Course, University ofMichigan Department of Pediatrics

1997 "Diabetes: The Old and the New," Physician and Community Outreach,Mercy Medical Center, Cadillac, Michigan

Foster, Page 12

Page 13: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

1997 "Workshop in Pediatric Diabetes Management," Endocrinology andMetabolism Section, University of Michigan Department of Internal Medicine,Ann Arbor, Michigan

1998 "Newborn Screening for Congenital Adrenal Hyperplasia," Michigan PediatricEndocrinologists, Ann Arbor, Michigan

1998 "The Short Child," Update in Family Practice, Post Graduate Education,University of Michigan, Ann Arbor, Michigan

1998 "Thyroid Diseases in Children," Genesys Regional Medical Center, GrandBlanc, Michigan

2001 "Diabetes Mellitus in Children," Genesys Regional Medical Center CoglinLecture, Grand Blanc, Michiga

2001 "Short Stature," Genesys Regional Medical Center Coglin Lecture GrandBlanc, Michigan

2002 "Control of FSH During Puberty," Case Western University Departments ofPediatrics and Endocrinology

2002 "Hypoglycemia, Diabetes Mellitus and Thyroid Disorders," Pediatric BoardReview Course, University of Michigan Department of Pediatrics

2002 - 2004 Pediatric Board Review Course--Endocrinology Disorders, University ofMichigan Department of Pediatrics, Ann Arbor, MI

2002 "Precocious Puberty," 11th Annual Primary Health Care of WomenUniversity of Michigan Departments of Family Medicine and Obstetrics andGynecology

2003 "The Role of FSH in Sex Differences in the Timing of Puberty," University ofUtah Department of Pediatrics, Salt Lake City, UT

2004 "Newborn Screening for Congenital Hypothyroidism," American Associationof Clinical Endocrinologists, Michigan Chapter Annual Meeting

2006 Childhood Obesity, Association of Diabetes Educators of Utah2007 Metabolic Syndrome in Children, Utah Pediatric Nurse Practitioners

Conference2008 - Present Precocious Puberty and Low Gonadotropins

Pediatric Endocrinologists of the Rocky Mountains2009 - Present Premature Puberty

Rocky Mountain Chapter of the American Association of ClinicalEndocrinologists

2009 - Present Dysfunctional Uterine BleedingPediatric Endocrinologists of the Rocky Mountains

2009 - Present Effect of Critical Illness on Thyroid FunctionICU Lecture Series

2010 - Present Evaluation of Short Stature, Grand Rounds, Utah Valley Regional MedicalCenter

PEER-REVIEWED JOURNAL ARTICLES1. Foster CM, Eisen HJ, Bloomfield CD (1983). Covalent labeling of rat thymocyte and human

lymphoid glucocorticoid receptor. Cancer Res, 43(11), 5273-7.2. Foster CM, Ross JL, Shawker T, Pescovitz OH, Loriaux DL, Cutler GB Jr, Comite F (1984).

Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome. J ClinEndocrinol Metab, 58(6), 1161-5.

Foster, Page 13

Page 14: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

3. Foster CM, Comite F, Pescovitz OH, Ross JL, Loriaux DL, Cutler GB Jr (1984). Variable responseto a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albrightsyndrome. J Clin Endocrinol Metab, 59(4), 801-5.

4. Reichman ME, Foster CM, Eisen LP, Eisen HJ, Torain BF, Simons SS Jr (1984). Limitedproteolysis of covalently labeled glucocorticoid receptors as a probe of receptor structure.Biochemistry, 23(22), 5376-84.

5. Tomita M, Chrousos GP, Brandon DD, Ben-Or S, Foster CM, De Vougn L, Taylor S, Loriaux DL,Lipsett MB (1985). Glucocorticoid receptors in Epstein-Barr virus-transformed human lymphocytes.Horm Metab Res, 17(12), 674-8.

6. Schwartz J, Foster CM, Satin MS (1985). Growth hormone and insulin-like growth factors I and IIproduce distinct alterations in glucose metabolism in 3T3-F442A adipocytes. Proc Natl Acad Sci U SA, 82(24), 8724-8.

7. Pescovitz OH, Comite F, McNemar A, Hench K, Barnes K, Foster CM, Keningsberg D, LoriauxDL, Cutler GB Jr (1986). The NIH experience in precocious puberty: Diagnostic subgroups and theresponse to short-term LHRH analogue therapy. J Pediatr, 108, 47.

8. Schwartz J, Foster CM (1986). Pituitary and recombinant deoxyribonucleic acid-derived humangrowth hormones alter glucose metabolism in 3T3 adipocytes. J Clin Endocrinol Metab, 62(4), 791-4.

9. Tomita M, Brandon DD, Chrousos GP, Vingerhoeds AC, Foster CM, Fowler D, Loriaux DL,Lipsett MB (1986). Glucocorticoid receptors in Epstein-Barr virus-transformed lymphocytes frompatients with glucocorticoid resistance and a glucocorticoid-resistant New World primate species. JClin Endocrinol Metab, 62(6), 1145-54.

10. Foster CM, Feuillan P, Padmanabhan V, Pescovitz OH, Beitins IZ, Comite F, Shawker TH, LoriauxDL, Cutler GB Jr (1986). Ovarian function in girls with McCune-Albright syndrome. Pediatr Res,20(9), 859-63.

11. Feuillan PP, Foster CM, Pescovitz OH, Hench KD, Shawker T, Dwyer A, Malley JD, Barnes K,Loriaux DL, Cutler GB Jr (1986). Treatment of precocious puberty in the McCune-Albrightsyndrome with the aromatase inhibitor testolactone. N Engl J Med, 315(18), 1115-9.

12. Foster CM, Shafer JA, Rozsa FW, Wang XY, Lewis SD, Renken DA, Natale JE, Schwartz J,Carter-Su C (1988). Growth hormone promoted tyrosyl phosphorylation of growth hormone receptorsin murine 3T3-F442A fibroblasts and adipocytes. Biochemistry, 27(1), 326-34.

13. Hale PM, Khoury S, Foster CM, Beitins IZ, Hopwood NJ, Marshall JC, Kelch RP (1988).Increased luteinizing hormone pulse frequency during sleep in early to midpubertal boys: effects oftestosterone infusion. J Clin Endocrinol Metab, 66(4), 785-91.

14. Foster CM, Hale PM, Jing HW, Schwartz J (1988). Effects of human growth hormone on insulin-stimulated glucose metabolism in 3T3-F442A adipocytes. Endocrinology, 123(2), 1082-8.

15. Padmanabhan V, Kelch RP, Sonstein J, Foster CM, Beitins IZ (1988). Bioactive follicle-stimulatinghormone responses to intravenous gonadotropin-releasing hormone in boys with idiopathichypogonadotropic hypogonadism. J Clin Endocrinol Metab, 67(4), 793-800.

16. Foster CM, Hopwood NJ, Hassing JM, Hale PM, Mendes T, Kelch RP, Beitins IZ (1989).Nocturnal serum growth hormone concentration is not augmented by short-term testosterone infusionin pubertal boys. Pediatr Res, 26(4), 320-4.

17. Foster CM, Hassing JM, Mendes TM, Hale PM, Padmanabhan V, Hopwood NJ, Beitins IZ,Marshall JC, Kelch RP (1989). Testosterone infusion reduces nocturnal luteinizing hormone pulsefrequency in pubertal boys. J Clin Endocrinol Metab, 69(6), 1213-20.

Foster, Page 14

Page 15: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

18. Hassing JM, Padmanabhan V, Kelch RP, Brown MB, Olton PR, Sonstein JS, Foster CM, Beitins IZ(1990). Differential regulation of serum immunoreactive luteinizing hormone and bioactive follicle-stimulating hormone by testosterone in early pubertal boys. J Clin Endocrinol Metab, 70(4), 1082-9.

19. Kletter GB, Foster CM, Brown MB, Padmanabhan V, Beitins IZ, Marshall JC, Kelch RP (1991).Naloxone does not reverse the suppressive effects of testosterone infusion on luteinizing hormonesecretion in pubertal boys. J Clin Endocrinol Metab, 73(6), 1241-7.

20. Foster CM, Hopwood NJ, Beitins IZ, Mendes TM, Kletter GB, Kelch RP (1992). Evaluation ofgonadotropin responses to synthetic gonadotropin-releasing hormone in girls with idiopathichypopituitarism. J Pediatr, 121(4), 528-32.

21. Kletter GB, Foster CM, Beitins IZ, Marshall JC, Kelch RP (1992). Acute effects of testosteroneinfusion and naloxone on luteinizing hormone secretion in normal men. J Clin Endocrinol Metab,75(5), 1215-9.

22. Foster CM (1993). Endocrine aspects of the McCune Albright Syndrome. Endocrinologist, The, 3,359-364.

23. Foster CM, Borondy M, Padmanabhan V, Schwartz J, Kletter GB, Hopwood NJ, Beitins IZ (1993).Bioactivity of human growth hormone in serum: validation of an in vitro bioassay. Endocrinology,132(5), 2073-82.

24. Kletter GB, Padmanabhan V, Foster CM, Brown MB, Kelch RP, Beitins IZ (1993). Luteinizinghormone pulse characteristics in early pubertal boys are the same whether measured byradioimmuno- or immunofluorometric assay. J Clin Endocrinol Metab, 76(5), 1173-6.

25. Foster CM, Borondy M, Markovs ME, Hopwood NJ, Kletter GB, Beitins IZ (1994). Growthhormone bioactivity in girls with Turner's syndrome: correlation with insulin-like growth factor I.Pediatr Res, 35(2), 218-22.

26. Kletter GB, Foster CM, Brown MB, Beitins IZ, Marshall JC, Kelch RP (1994). Nocturnal naloxonefails to reverse the suppressive effects of testosterone infusion on luteinizing hormone secretion inpubertal boys. J Clin Endocrinol Metab, 79(4), 1147-51.

27. Foster CM, Hopwood NJ, Montag CL, Sady MA (1995). Newborn screening from 21-hydroxylasedeficiency in the State of Michigan. AAP Grand Rounds, 16, 1-5.

28. Foster CM, Hashimoto N, Randolph JF Jr, Beitins IZ (1995). Comparison of growth hormone andinsulin-like growth factor-I regulation of estradiol and progesterone production in human luteinizedgranulosa cells. Pediatr Res, 38(5), 763-7.

29. Cemeroglu AP, Foster CM, Warner R, Kletter GB, Marshall JC, Kelch RP (1996). Comparison ofthe neuroendocrine control of pubertal maturation in girls and boys with spontaneous puberty and inhypogonadal girls. J Clin Endocrinol Metab, 81(12), 4352-7.

30. Frey MA, Guthrie B, Loveland-Cherry C, Park PS, Foster CM (1997). Risky behavior and risk inadolescents with IDDM. J Adolesc Health, 20(1), 38-45.

31. Bradbury FA, Kawate N, Foster CM, Menon KM (1997). Post-translational processing in the Golgiplays a critical role in the trafficking of the luteinizing hormone/human chorionic gonadotropin receptorto the cell surface. J Biol Chem, 272(9), 5921-6.

32. Cemeroglu AP, Barkan AL, Kletter GB, Beitins IZ, Foster CM (1997). Changes in serumimmunoreactive and bioactive growth hormone concentrations in boys with advancing puberty and inresponse to a 20-hour estradiol infusion. J Clin Endocrinol Metab, 82(7), 2166-71.

33. Kletter GB, Padmanabhan V, Beitins IZ, Marshall JC, Kelch RP, Foster CM (1997). Acute effectsof estradiol infusion and naloxone on luteinizing hormone secretion in pubertal boys. J ClinEndocrinol Metab, 82(12), 4010-4.

Foster, Page 15

Page 16: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

34. Cemeroglu AP, Kletter GB, Guo W, Brown MB, Kelch RP, Marshall JC, Padmanabhan V, FosterCM (1998). In pubertal girls, naloxone fails to reverse the suppression of luteinizing hormonesecretion by estradiol. J Clin Endocrinol Metab, 83(10), 3501-6.

35. Foster CM, Phillips DJ, Wyman T, Evans LW, Groome NP, Padmanabhan V (2000). Changes inserum inhibin, activin and follistatin concentrations during puberty in girls. Hum Reprod, 15(5), 1052-7.

36. Keenan HT, Foster CM, Bratton SL (2002). Social factors associated with prolonged hospitalizationamong diabetic children. Pediatrics, 109(1), 40-4.

37. Kasa-Vubu JZ, Barkan A, Olton P, Meckmongkol T, Carlson NE, Foster CM (2002). Incompletemodified fast in obese early pubertal girls leads to an increase in 24-hour growth hormoneconcentration and a lessening of the circadian pattern in leptin. J Clin Endocrinol Metab, 87(4),1885-93.

38. Foster CM, Olton PR, Racine MS, Phillips DJ, Padmanabhan V (2004). Sex differences in FSH-regulatory peptides in pubertal age boys and girls and effects of sex steroid treatment. Hum Reprod,19(7), 1668-76.

39. Racine MS, Symons KV, Foster CM, Barkan AL (2004). Augmentation of growth hormonesecretion after testosterone treatment in boys with constitutional delay of growth and adolescence:evidence against an increase in hypothalamic secretion of growth hormone-releasing hormone. J ClinEndocrinol Metab, 89(7), 3326-31.

40. Elsholz DD, Padmanabhan V, Rosenfield RL, Olton PR, Phillips DJ, Foster CM (2004). GnRHagonist stimulation of the pituitary-gonadal axis in children: age and sex differences in circulatinginhibin-B and activin-A. Hum Reprod, 19(12), 2748-58.

41. Foster CM, Olton PR, Padmanabhan V (2005). Diurnal changes in FSH-regulatory peptides andtheir relationship to gonadotrophins in pubertal girls. Hum Reprod, 20(2), 543-8.

42. McCartney CR, Prendergast KA, Chhabra S, Eagleson CA, Yoo R, Chang RJ, Foster CM,Marshall JC (2006). The association of obesity and hyperandrogenemia during the pubertal transitionin girls: obesity as a potential factor in the genesis of postpubertal hyperandrogenism. J ClinEndocrinol Metab, 91(5), 1714-22.

43. McCartney CR, Blank SK, Prendergast KA, Chhabra S, Eagleson CA, Helm KD, Yoo R, Chang RJ,Foster CM, Caprio S, Marshall JC (2007). Obesity and sex steroid changes across puberty:evidence for marked hyperandrogenemia in pre- and early pubertal obese girls. J Clin EndocrinolMetab, 92(2), 430-6.

44. Watkins MG, Clark KM, Foster CM, Welch KB, Kasa-Vubu JZ (2007). Relationships among bodymass index, parental perceptions, birthweight and parental weight after referral to a weight clinic. JNatl Med Assoc, 99(8), 908-13.

45. Foster CM, Barkan A, Kasa-Vubu JZ, Jaffe C (2007). Ghrelin concentrations reflect body massindex rather than feeding status in obese girls. Pediatr Res, 62(6), 731-4.

46. Opipari-Arrigan L, Fredericks EM, Burkhart N, Dale L, Hodge M, Foster C (2007). Continuoussubcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetesmellitus. Pediatr Diabetes, 8(6), 377-383.

47. Berg CA, Butler JM, Osborn P, King G, Palmer DL, Butner J, Murray M, Lindsay R, Donaldson D,Foster C, Swinyard M, Wiebe DJ (2008). Role of parental monitoring in understanding the benefitsof parental acceptance on adolescent adherence and metabolic control of type 1 diabetes. DiabetesCare, 31(4), 678-83.

Foster, Page 16

Page 17: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

48. Palmer DL, Berg CA, Butler J, Fortenberry K, Murray M, Lindsay R, Donaldson D, Swinyard M,Foster C, Wiebe DJ (2009). Mothers', fathers', and children's perceptions of parental diabetesresponsibility in adolescence: examining the roles of age, pubertal status, and efficacy. J PediatrPsychol, 34(2), 195-204.

49. Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, ESPE-LWPES GnRH Analogs ConsesnsuConference Group, Antoniazzi F, Berebaum S, Bourguignon JP, Chrousos GP, Coste J, Deal S, deVries L, Foster C, Heger S, Holland J, Jahnukainen K, Juul A, Kaplowitz P, Lahlou N, Lee MM,Lee P, Merke DP, Neely EK, Oostdijk W, Phillip M, Rosenfield RL, Shulman D, Styne D, Tauber M,Wit JM (April 2009). Consensus statement on the use of gonadotropin-releasing hormone analogs inchildren. Pediatrics, 123(4), e752-762.

50. Butler JM, Berg CA, King P, Gelfand D, Fortenberry K, Foster C, Wiebe D (2009). Parentalnegative affect and adolescent efficacy for diabetes management. J Fam Psychol, 23(4), 611-4.

51. Wiebe DJ, Croom A, Fortenberry KT, Butner J, Butler J, Swinyard MT, Lindsay R, Donaldson D,Foster C, Murray M, Berg CA (March 2010). Parental Involvement Buffers Associations BetweenPump Duration and Metabolic Control among Adolescents with Type 1 Diabetes. J Pediatr Psychol.

52. Kichler JC, Foster C, Opipari-Arrigan L (April 2008). The relationship between negativecommunication and body image dissatisfaction in adolescent females with Type 1 Diabetes Mellitus. JHealth Psychol, 13(3), 336-347.

53. Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA, STAR 3 Study Group(2010). Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.. N Engl J Med,363(4), 311-20.

54. Wiebe DJ, Croom A, Fortenberry KT, Butner J, Butler J, Swinyard MT, Lindsay R, Donaldson D,Foster C, Murray M, Berg CA (2010). Parental involvement buffers associations between pumpduration and metabolic control among adolescents with type 1 diabetes. J Pediatr Psychol, 35(10),1152-60.

55. Croom A, Wiebe DJ, Berg CA, Lindsay R, Donaldson D, Foster C, Murray M, Swinyard MT(2011). Adolescent and parent perceptions of patient-centered communication while managing type 1diabetes. J Pediatr Psychol, 36(2), 206-15.

56. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Perkins BA,Welsh JB, Willi SM, Wood MA, STAR 3 Study Group (2011). Sensor-augmented pump therapy forA1C reduction (STAR 3) study: results from the 6-month continuation phase.. Diabetes Care,34(11), 2403-5.

57. Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Perkins BA,Welsh JB, Willi SM, Wood MA, STAR 3 Study Group (2011). Sensor-augmented pump therapy forA1C reduction (STAR 3) study: results from the 6-month continuation phase. Diabetes Care, 34(11),2403-5.

58. Slover RH, Welsh JB, Criego A, Weinzimer SA, Willi SM, Wood MA, Tamborlane WV (2012).Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes inthe STAR 3 study.. Pediatr Diabetes, 13(1), 6-11.

59. King PS, Berg CA, Butner J, Drew LM, Foster C, Donaldson D, Murray M, Swinyard M, Wiebe DJ(2012). Longitudinal trajectories of metabolic control across adolescence: associations with parentalinvolvement, adolescents' psychosocial maturity, and health care utilization. J Adolesc Health, 50(5),491-6.

60. Berg CA, Hughes AE, King PS, Korbel C, Fortenberry KT, Donaldson D, Foster C, Swinyard M,Wiebe DJ (March 1, 2014). Self-control as a mediator of the link between intelligence and HbA1cduring adolescence. Child Health Care, 43(2), 120-131.

Foster, Page 17

Page 18: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

NON PEER-REVIEWED JOURNAL ARTICLES1. Foster CM, Kelch RP (1986). New hope for youngsters with precocious puberty. Contemporary

Pediatrics, 3, 105-123.2. Kemper AR, Foster CM (2003). Congenital Hypothyroidism: A guide for the general pediatrician.

Contemporary Pediatrics, 20, 32-48.

REVIEW ARTICLES1. Cutler GB Jr, Cassorla FG, Ross JL, Pescovitz OH, Barnes KM, Comite F, Feuillan PP, Laue L,

Foster CM, Kenigsberg D, et al (1986). Pubertal growth: physiology and pathophysiology. [Review].Recent Prog Horm Res, 42, 443-70.

BOOK CHAPTERS1. Bloomfield CD, Holbrook NJ, Munck AU, Foster CM, Eisen HJ, Smith KA (1983). Glucocorticoid

receptors - in vitro clinical correlations in human leukemia and lymphoma. In Bresciani F, King JBK,Lippman ME, Nanner M, Reynaud JP (Eds.), Progress in Cancer Research Therapy (31, pp. 229-244). New York: Raven Press.

2. Comite F, Pescovitz OH, Foster CM, Cassorla F, Hench K, McNemar A, Skerda M. Loriaux DL,Cutler GB Jr (1984). LHRH analog effect on pubertal development, growth and maturation inprecocious puberty. In Labrie F, Belanger A, Dupont A (Eds.), Workshop on LHRH Analogs (pp.438-454). Amsterdam: Elsevier Science Publishers B.V.

3. Kelch RP, Foster CM, Kletter GB, Sauder SE, Marshall JC (1989). Changes in gonadotropin-releasing hormone (GnRH) secretion during human puberty. In Control of the Onset of Puberty III(pp. 169-181). Amsterdam: Elsevier.

4. Schwartz J, Carter-Su C, Foster CM, Shafer JA (1989). Direct actions of growth hormone andinsulin-like growth factor in cultured adipocytes. In Miller EE, Cocchi D, Locatelli V (Eds.), Advancesin Growth Hormone and Growth Factor Research (pp. 85-100). Berlin-Heidelberg: PythagoraPress, Roma-Milano and Springer Verlag.

5. Hopwood NJ, Kelch RP, Hale PM, Mendes TM, Foster CM, Beitins IZ (1990). The onset of humanpuberty - biological and environmental factors. In Bancroft J, Reinish JM, The Kinsey Institute Series(Eds.), Adolescence and Puberty (III, pp. 29-49). New York: Oxford University Press.

6. Kelch RP, Foster CM, Kletter GB, Marshall JC (1990). Neuroendocrine regulation of puberty inboys. In Sizonenko PC, Aubert ML (Eds.), International Symposium on DevelopmentalEndocrinology (pp. 103-115). New York: Raven Press.

7. Foster CM (1991). Early and delayed sexual maturation. In Conn RB (Ed.), Current Diagnosis (pp.1294-1301). Philadelphia: WB Saunders.

8. Foster CM (1998). Adolescent Menstrual Abnormalities. In Lifshitz F (Ed.), PediatricEndocrinology (pp. 223-234). New York: Marcel-Decker.

9. Foster CM (2001). Dysmenorrhea. In Stockman JA III, Lohr JA (Eds.), Essence of OfficePediatrics (p. 121). Philadelphia: WB Saunders.

CONFERENCE PROCEEDINGS1. Kletter GB, Foster CM, Kelch RP, Castracane VD (2004). Inhibin B concentrations increase during

pubertal development in boys. Lisbon: Proceedings of the 12th International Congress ofEndocrinology.

OTHER (Commentary/Letters/Editorials/Case Reports/Video/Film)

Foster, Page 18

Page 19: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

Case Reports1. Foster CM, Pescovitz OH, Comite F, Feuillan P, Shawker T, Loriaux DL, Cutler GB Jr (1985).

Testolactone treatment of precocious puberty in McCune-Albright syndrome. Acta Endocrinol(Copenh), 109(2), 254-7.

2. Foster CM, Levin S, Levine M, Mukherjee A, Costa JL, Eanes ED, Triche T, Zasloff M (1986).Limited dermal ossification: clinical features and natural history. J Pediatr, 109(1), 71-6.

Editorials1. Foster CM (2006). Editorial: does lupron dosage make a difference in outcome when treating children

with precocious puberty? J Clin Endocrinol Metab, 91(5), 1667-8.

Video/Film/CD/Web/Podcast1. Foster CM, Rosen DS (2000). Sexual Development. In: Grolier Multimedia Encyclopedia (CD-ROM,

Internet) [CD].

UNPUBLISHED POSTER PRESENTATIONS1. Mutyala M, Hamaker M, Foster C, Clements SA (09/2017). Maternal amiodarone causing

neonatal goiter and hypothyroidism. Poster session presented at the 10th International Meetingof Pediatric Endocrinology, Washington D.C. Poster session presented at 10th InternationalMeeting of Pediatric Endocrinology, Washington, DC.

ORAL PRESENTATIONS

Meeting Presentations (Not Published Abstracts and Not Unpublished Posters)International1992 Foster CM, Padmanabhan V. Borondy M, Beitins IZ. Clinical applications of an in

vitro bioassay for growth hormone in human serum. Presented at the InternationalSymposium on Growth Hormone II: Basic Clinical Aspects, Tarpon Springs, FL

1993 Kletter GB, Rolfes-Curl A, Liu H, Foster CM, Kelch RP, Beitins IZ. Naloxoneincreases the rate of pulsatile LH secretion but not FSH in pubertal girls withhyperprolactonemia. Presented at the International Symposium on OvarianFunction and Induction of Ovulation, Tel Aviv, Israel

National1984 Tomita M, Chrousos GP, Brandon D, Ben-Or S, Foster C, Taylor S, Loriaux DL,

Lipsett MB. Effects of viral transformation on the human glucocorticoid receptor.Presented to the American Federation for Clinical Research, Washington DC

1987 Foster CM, Hale PM, Schwartz J. Effects of growth hormone on insulin stimulatedglucose metabolism. Presented at the 3rd Biennial Director's Meeting of the CRC,Williamsburg, Virginia

1993 Kletter GB, Foster CM, Zawacki CM, Kersey KM, Kelch RP. In pubertal boys,naloxone fails to reverse the suppression of LH secretion by estradiol infusion.Presented at the 75th Annual Meeting of the Endocrine Society, Las Vegas, NV

1994 Meyers C, Naber J, Scott J, Foster CM, Hopwood NJ. Implementation ofcongenital adrenal hyperplasia (CAH) into a newborn screening program.Presented at the 10th National Neonatal Screening Symposium, Seattle, WA

Foster, Page 19

Page 20: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

1994 Sady M. Meyers C, Dwass C, Foster CM, Hopwood NJ. Follow-uprecommendation for abnormal screens for congenital adrenal hyperplasia (CAH).Presented at the 10th National Neonatal Screening Symposium, Seattle, WA

2003 Marshall JC, Eagleson CA, McCartney CR, Prendergast KA, Chhabra SK,Bellows AM, Foster CM. Androgens modulate steroid feedback in women withPCOS*Implications for pubertal maturation. 2003 Neuroendocrine Workshop,Baltimore, MD

2004 Malauin RA, Young WI, Pleger D, Andruszewski K, Hawkins H, Cavanagh K,Foster CM. Redefining cut-off points for congenital hypothyroidism in Michigan.Newborn Screening and Genetic Testing Symposium, Atlanta, GA

2005 Kichler JC, Foster C, Opipari-Arrigan L. Negative communication and bodydissatisfaction in adolescent females with type 1 diabetes mellitus. Presented at thePediatric Academic Societies Annual Meeting, Washington, DC

2005 Opipari L, Kichler J, Fredericks E, Burkhart N, Dale L, Eder S, Bratton S, FosterC. Self-management training improves diabetes-related family functioning amongeconomically disadvantaged adolescents with type 1 diabetes mellitus. Presented atthe Pediatric Academic Societies Annual Meeting, Washington, DC

2005 Arslanian S, Foster C, Wright N, Stender S, Hu P, Hale P, Hale D. Comparison ofInsulin Aspart, Regular Insulin, and Insulin Lispro in Basal Bolus Therapy WithNPH To Treat Pediatric Patients With Type 1 Diabetes Mellitus. AmericanDiabetes Association 65th Annual Meeting, San Diego

2006 CHILDx Sixth Annual Fall Symposium, Salt Lake City, Utah, Precocious PubertyLocal/Regional1995 Dwass CN, Rucker DR, Hoeft-Loyer CM, Montag CL, Naber JM, Foster CM,

Hopwood NJ. A review of positive newborn screens for congenital adrenalhyperplasia (CAH) in Michigan. 11th National and 1st North American RegionalNeonatal Screening Symposium, Corpus Cristi, TX

2005 Pediatric Endocrinologists of the Rocky Mountains, The role of FSH in theRegulation of Puberty

2009 Foster, Carol. "Precocious Puberty: Not So Precious." Rocky Mountain Chapter ofthe American Association of Clinical Endocrinologists Annual Meeting. Salt LakeCity, Utah

2015 Subclinical Hypothyroidism in Children, Pediatric Endocrinology of the RockyMountains

Invited/Visiting Professor PresentationsInternational1988 Cutler GB Jr, Feuillan PP, Foster CM, Pescovitz OM, Loriaux DL.

Pathophysiology and treatment of McCune-Albright Syndrome. InvitedPresentation at the 8th International Congress of Endocrinology, Kyoto, Japan

National2006 FSH and the Onset of Puberty at the NIA/NICHD Workshop on Factors in Youth

that Protect Against Aging Processes

Grand Rounds Presentations1995 "Precocious Puberty," Pediatric Grand Rounds, Henry Ford Hospital

Foster, Page 20

Page 21: Curriculum Vitae - University of Utah€¦ · Curriculum Vitae Last Updated: 04/27/2018 PERSONAL DATA Name: Carol M. Foster ... Page 1. 1997 - 1998 Interim Director, University of

1998 "Problems of Puberty," Oakwood Hospital Pediatric Grand Rounds Dearborn,Michigan,

1999 "Bioactivity of Growth Hormone," University of Washington Endocrine Rounds,Seattle, Washington

1999 "Puberty Disorders," Hurley Hospital Pediatric Grand Rounds Flint, Michigan1999 "Adrenogenital Syndrome," Hurley Hospital Pediatric Grand Rounds, Flint,

Michigan2000 "Management of Diabetes in Children and Adolescents," Bon Secours Grand

Rounds Grosse Point, Michigan2001 "Thyroid Disorders in Children," Crittenden Hospital Pediatric Grand Rounds,

Grand Blanc, Michigan2008 Thriving to Fail, Pediatric Grand Rounds2010 Evaluation of Short stature, Utah Valley Regional Medical Center, Pediatric Grand

Rounds

OTHER SCHOLARLY ACTIVITIES

Clinical Studies2006 - 2007 FSH and the Onset of Puberty--Ganirelix. General Clinical Research Center Study

05-262007 - 2008 Medtronics Star 32008 - Present An Open-label, Non-Comparative Trial to Evaluate the Safety, Efficacy and

Pharmacokinetics of FASLODEX™ (fulvestrant) in Girls with ProgressivePrecocious Puberty Associated with McCune-Albright Syndrome

2008 - Present A Phase 3, Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacyand Safety of Leuprolide Acetate 11.25 mg and 30 mg Formulation in Children withCentral Precocious Puberty Protocol # L-CP07-167

Other Scholarly Activities2007 Workshop on GnRH analog uses, Milan, Italy

Foster, Page 21